BARCLAYS PLC - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 70 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$11,000
-97.6%
9,347
-93.3%
0.00%
Q4 2021$456,000
+128.0%
139,754
+211.5%
0.00%
Q3 2021$200,000
-37.5%
44,863
-23.7%
0.00%
Q2 2021$320,000
-44.5%
58,761
-23.7%
0.00%
Q1 2021$577,000
+284.7%
77,044
+460.6%
0.00%
Q4 2020$150,000
-10.7%
13,742
-27.9%
0.00%
Q3 2020$168,000
-31.1%
19,050
-16.7%
0.00%
Q2 2020$244,000
+258.8%
22,877
+99.1%
0.00%
Q1 2020$68,000
-72.2%
11,490
-67.7%
0.00%
Q4 2019$245,000
+32.4%
35,569
+98.8%
0.00%
Q3 2019$185,000
-10.6%
17,889
-19.9%
0.00%
Q2 2019$207,000
+204.4%
22,347
+200.0%
0.00%
Q1 2019$68,000
+300.0%
7,449
+154.1%
0.00%
Q4 2018$17,000
-88.7%
2,931
-76.7%
0.00%
Q3 2018$150,000
+733.3%
12,566
+600.4%
0.00%
Q2 2018$18,000
-56.1%
1,794
-44.0%
0.00%
Q1 2018$41,000
+115.8%
3,205
+61.5%
0.00%
Q4 2017$19,000
+280.0%
1,984
+411.3%
0.00%
Q3 2017$5,000388
+4750.0%
0.00%
Q2 2017$08
-66.7%
0.00%
Q1 2017$024
-25.0%
0.00%
Q4 2016$0
-100.0%
32
-91.4%
0.00%
Q3 2016$5,0003710.00%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 4,806,656$58,449,00019.02%
Casdin Capital, LLC 182,141$2,215,0001.83%
Aisling Capital LLC 508,565$6,184,0001.44%
Redmile Group, LLC 948,440$11,533,0000.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,812,778$22,043,0000.91%
EcoR1 Capital, LLC 63,596$773,0000.25%
Eventide Asset Management 150,000$1,824,0000.12%
AWM Investment Company, Inc. 47,550$578,0000.11%
Weiss Multi-Strategy Advisers LLC 49,000$596,0000.03%
Baker Brothers Advisors 204,465$2,486,0000.02%
View complete list of SYROS PHARMACEUTICALS INC shareholders